Cardiomyocyte hypertrophy co-localizes with accumulation of hyaluronan in cMyBPC+/- mice hearts
PLOS One · 2026
DOI: 10.1371/journal.pone.0342635 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Anna Strnadová und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Hyaluronic Acid, Myocytes, Cardiac, Carrier Proteins, Myocardium. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Västerbotten, Norrlandska Hjärtfonden.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by left ventricular hypertrophy. Mutations in genes for sarcomere proteins, e.g., in cardiac myosin-binding protein C (cMyBPC), may cause symptoms like heart failure and sudden cardiac death. In HCM, the heart utilizes high amounts of glucose. Increased glucose metabolism creates intermediates for hyaluronan (HA) synthesis, resulting in HA accumulation within the extracellular space, which could contribute to cardiomyocyte hypertrophy. We aimed to describe the connection between HA and cardiomyocyte hypertrophy using cMyBPC +/- mice treated with two different β-blockers – either metoprolol or propranolol – for 11 months. The results showed that HA metabolism is altered in HCM, and that HA is significantly more abundant in hearts of cMyBPC +/- mice compared to wild-type mice. Areas of high HA abundance were spread around the tissue in a ‘patchy’ manner. This focally increased HA concentration correlated with increased cardiomyocyte size in the same areas of the heart. Gene expression of HA synthase 2 was elevated in cMyBPC +/- mice. Treatment with propranolol maintained HA synthase 2 at wild-type level, while significantly increasing HA synthase 3 expression. However, treatment with metoprolol or propranolol did not prevent HA accumulation nor decreased cardiomyocyte hypertrophy. These novel findings visualise a spatial connection between high HA abundance and cardiomyocyte hypertrophy in the hearts of cMyBPC +/- mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
- Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
- Umeå Centre for Molecular Medicine, Umeå University, Umeå, Sweden.
- Department of Chemistry, Umeå University, Umeå, Sweden.
- Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
ORCID-Profile: Anna Strnadová, Madelene Ericsson, Rakel Nyrén, Urban Hellman
Förderung
- Region Västerbotten
- Norrlandska Hjärtfonden
Zitieren
APA
Strnadová, A., Ericsson, M., Nyrén, R., Dudka, I., Mörner, S., & Hellman, U. (2026). Cardiomyocyte hypertrophy co-localizes with accumulation of hyaluronan in cMyBPC+/- mice hearts. PLOS One. https://doi.org/10.1371/journal.pone.0342635
Vancouver
Strnadová A, Ericsson M, Nyrén R, Dudka I, Mörner S, Hellman U. Cardiomyocyte hypertrophy co-localizes with accumulation of hyaluronan in cMyBPC+/- mice hearts. PLOS One. 2026. doi:10.1371/journal.pone.0342635
BibTeX
@article{Strnadov2026,
author = {Strnadová, Anna and Ericsson, Madelene and Nyrén, Rakel and Dudka, Ilona and Mörner, Stellan and Hellman, Urban},
title = {Cardiomyocyte hypertrophy co-localizes with accumulation of hyaluronan in cMyBPC+/- mice hearts},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0342635}
}
EUVIMED